Gender inequality in genitourinary malignancies clinical trials leadershipAbdulrahman Alhajahjeh, Mohammed Shahait, Bashir Al Hussein Al Awamlh et al.|World Journal of Urology|2024Cited by 4
Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular RiskStacey M. Frumm, Maximilian Stahl, Haesook T. Kim et al.|Blood|2023Cited by 0
A Simple Prediction Model of Outcomes after Allogeneic Hematopoietic Stem Cell Transplant (HCT) in Myelodysplastic Syndromes Using HCT-Comorbidity Index, Cytogenetic Risk, and Platelet CountStacey M. Frumm, Maximilian Stahl, Haesook T. Kim et al.|Blood|2023Cited by 0